4-Aroylimidazol-2-ones and their use as pharmaceuticals
    2.
    发明授权
    4-Aroylimidazol-2-ones and their use as pharmaceuticals 失效
    4-芳酰基咪唑-2-酮及其作为药物的用途

    公开(公告)号:US4405635A

    公开(公告)日:1983-09-20

    申请号:US417805

    申请日:1982-09-13

    IPC分类号: C07D233/70 A61K31/415

    CPC分类号: C07D233/70

    摘要: Novel 4-aroylimidazol-2-ones of the following general structure which are useful as antihypertensives, cardiotonics, antithrombotics, bronchodilators and uterospasmolytics ##STR1## wherein Ar is 2-furyl, 2-thienyl or phenyl, the latter of which may optionally be substituted with one or two X groups; X is halogen, hydroxy, C.sub.1-4 alkyl, C.sub.1-4 alkoxy, methylenedioxy, C.sub.1-4 alkylthio, C.sub.1-4 alkylsulfoxide, C.sub.1-4 alkylsulfone, CF.sub.3, --SO.sub.2 N(R.sub.2).sub.2, NR.sub.3 R.sub.4, pyrrolidino, piperidino, morpholino, piperazino or N'-alkyl-piperazino, R is hydrogen, C.sub.1-4 alkyl, C.sub.1-4 alkylcarbonyl or benzyl; each of R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are hydrogen or C.sub.1-4 alkyl; and the pharmaceutically acceptable salts thereof.

    摘要翻译: 可用作抗高血压药,强心剂,抗血栓药物,支气管扩张剂和子宫解脂素的以下通用结构的新型4-芳酰基咪唑-2-酮其中Ar为2-呋喃基,2-噻吩基或苯基,后者可任选地被取代 与一个或两个X组; X是卤素,羟基,C 1-4烷基,C 1-4烷氧基,亚甲二氧基,C 1-4烷硫基,C 1-4烷基亚砜,C 1-4烷基砜,CF 3,-SO 2 N(R 2)2,NR 3 R 4,吡咯烷子基,哌啶子基,吗啉代, 哌嗪基或N'-烷基 - 哌嗪子基,R是氢,C 1-4烷基,C 1-4烷基羰基或苄基; R 1,R 2,R 3和R 4各自为氢或C 1-4烷基; 及其药学上可接受的盐。

    Substituted cycloalkyl lactamimides
    3.
    发明授权
    Substituted cycloalkyl lactamimides 失效
    取代的环丙基乳糖

    公开(公告)号:US4126611A

    公开(公告)日:1978-11-21

    申请号:US877663

    申请日:1978-02-14

    摘要: Compounds possessing hypoglycemic, hypotensive, antiinflammatory, anticoagulant and diuretic activity are represented by compounds of the following formula ##STR1## wherein Y is thienyl, cycloalkyl of from 5 to 7 carbon atoms, phenyl or substituted phenyl in which case the substituents on the substituted phenyl are selected from halogen, such as fluorine, chlorine, bromine or iodine, lower alkyl of from 1 to 4 carbon atoms and lower alkoxy of from 1 to 4 carbon atoms; Z is hydrogen or hydroxy; R is hydrogen, lower alkyl of from 1 to 4 carbon atoms, phenyl or benzyl; R.sup.1 is hydrogen, lower alkyl of from 1 to 4 carbon atoms or halogen, such as chlorine, fluorine, bromine or iodine; m is from 3 to 6; and n is from 3 to 11. Pharmaceutical compositions of these compounds and their use are also disclosed.

    摘要翻译: 具有降血糖,降血压,抗炎,抗凝血和利尿活性的化合物由下式的化合物表示,其中Y是噻吩基,5-7个碳原子的环烷基,苯基或取代的苯基,在这种情况下,取代基 取代的苯基选自卤素如氟,氯,溴或碘,1至4个碳原子的低级烷基和1至4个碳原子的低级烷氧基; Z是氢或羟基; R为氢,1至4个碳原子的低级烷基,苯基或苄基; R1是氢,1至4个碳原子的低级烷基或卤素,如氯,氟,溴或碘; m为3〜6; 并且n为3至11.这些化合物的药物组合物及其用途也被公开。

    Bis(aminoalkylsulfamoyl)anthraquinone antiviral agents
    7.
    发明授权
    Bis(aminoalkylsulfamoyl)anthraquinone antiviral agents 失效
    双(氨基烷基氨磺酰)蒽醌抗病毒剂

    公开(公告)号:US3983248A

    公开(公告)日:1976-09-28

    申请号:US169861

    申请日:1971-08-06

    IPC分类号: A61K31/18 C07C311/15

    CPC分类号: A61K31/18 C07C311/15

    摘要: Compounds useful as antiviral agents are those of the formula ##SPC1##Wherein each R.sup.1 is hydrogen or methyl; each n is an integer of 2 to 4; each of R.sup.2 and R.sup.3 is alkyl of 3 to 5 carbon atoms or alkenyl of 3 to 5 carbon atoms; or a pharmaceutically acceptable acid addition salt of said base. Pharmaceutical compositions are formed from these compounds with pharmaceutically acceptable carriers.

    摘要翻译: 可用作抗病毒剂的化合物是下式的化合物,其中每个R 1是氢或甲基; 每个n为2至4的整数; R2和R3各自为3至5个碳原子的烷基或3至5个碳原子的烯基; 或所述碱的药学上可接受的酸加成盐。 药物组合物由这些化合物与药学上可接受的载体形成。